Who Paid My Doc
Elizabeth Kaufman
Clinical Cardiac Electrophysiology Cleveland, OH
NPI 1366453474 CMS profile 942960
2500 Metrohealth Dr, Cleveland, OH 44109
General payments
$0
Research payments
$0
Ownership & investment interest
$0
The CMS Open Payments record contains no reported payments to Elizabeth Kaufman of Cleveland, OH.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
Prescribing to Medicare patients
Part D · data year 2024 · 27 drugsPart D claims
1,383
Drug cost
$415,104
Branded share of claims
30.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 176 | $197,279 | |
| Xarelto Rivaroxaban | Brand | 108 | $159,032 | |
| Farxiga Dapagliflozin Propanediol | Brand | 30 | $27,301 | |
| Dofetilide | Generic | 49 | $14,838 | |
| Metoprolol Succinate | Generic | 261 | $5,949 | |
| Nadolol | Generic | 15 | $1,673 | |
| Rosuvastatin Calcium | Generic | 30 | $1,637 | |
| Sotalol Sotalol Hcl | Brand | 47 | $1,375 | |
| Atorvastatin Calcium | Generic | 75 | $579 | |
| Losartan Potassium | Generic | 90 | $572 |
The 10 drugs with the highest cost, of 27 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 39 billing codesPaid by Medicare
$43,178
Medicare patients
370
Services billed
872
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Atrial fibrillation | 62% | |
| Arthritis | 50% | |
| Heart failure | 46% | |
| Ischemic heart disease | 42% | |
| Diabetes | 36% | |
| Chronic kidney disease | 30% | |
| COPD | 25% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Other Clinical Cardiac Electrophysiology in Ohio
Anish Amin
Clinical Cardiac Electrophysiology · Columbus, OH
Walid Saliba
Clinical Cardiac Electrophysiology · Cleveland, OH
Mohamed Kanj
Clinical Cardiac Electrophysiology · Beachwood, OH
John Hummel
Clinical Cardiac Electrophysiology · Columbus, OH
Bruce Wilkoff
Clinical Cardiac Electrophysiology · Cleveland, OH
Alexandru Costea
Clinical Cardiac Electrophysiology · Cincinnati, OH
Related records
Clinical Cardiac Electrophysiology in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Cardiac Electrophysiology
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.